Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Obesity × Aspirin × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Fallopian Tube Neoplasms 2 Venous Thromboembolism 1 Thrombosis 1 Obesity 1 Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

Tirzepatide 2 Metformin 2 Hydrocortisone 2 Ovidrel 1 Leuprolide 1 Dexamethasone 1 Cosyntropin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡